CN117264953A - dsRNA for inhibiting rice stripe virus, and preparation method and application thereof - Google Patents
dsRNA for inhibiting rice stripe virus, and preparation method and application thereof Download PDFInfo
- Publication number
- CN117264953A CN117264953A CN202311164495.7A CN202311164495A CN117264953A CN 117264953 A CN117264953 A CN 117264953A CN 202311164495 A CN202311164495 A CN 202311164495A CN 117264953 A CN117264953 A CN 117264953A
- Authority
- CN
- China
- Prior art keywords
- dsrna
- rice
- rice stripe
- virus
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091032973 (ribonucleotides)n+m Proteins 0.000 title claims abstract description 89
- 102000040650 (ribonucleotides)n+m Human genes 0.000 title claims abstract description 78
- 241000724205 Rice stripe tenuivirus Species 0.000 title claims abstract description 54
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 201000010099 disease Diseases 0.000 claims abstract description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 25
- 230000007918 pathogenicity Effects 0.000 claims abstract description 7
- 241000209094 Oryza Species 0.000 claims description 35
- 235000007164 Oryza sativa Nutrition 0.000 claims description 28
- 235000009566 rice Nutrition 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 11
- 239000002299 complementary DNA Substances 0.000 claims description 10
- 239000012634 fragment Substances 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 239000013598 vector Substances 0.000 claims description 7
- 239000013604 expression vector Substances 0.000 claims description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 241001131798 Escherichia coli HT115 Species 0.000 claims description 2
- 238000003259 recombinant expression Methods 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 abstract description 24
- 108090000623 proteins and genes Proteins 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 8
- 208000035240 Disease Resistance Diseases 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 230000009385 viral infection Effects 0.000 abstract description 2
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 241001470017 Laodelphax striatella Species 0.000 description 9
- 241000238631 Hexapoda Species 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 238000011081 inoculation Methods 0.000 description 6
- 230000009368 gene silencing by RNA Effects 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000030279 gene silencing Effects 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108091032955 Bacterial small RNA Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 208000006278 hypochromic anemia Diseases 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 239000005723 virus inoculator Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 1
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 1
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 1
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 1
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 1
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 1
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 1
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 1
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 1
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 1
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 1
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 1
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 1
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 1
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 1
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 1
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 1
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 1
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 1
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 1
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 1
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 1
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 1
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 1
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 1
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 1
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 1
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 1
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 1
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 1
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 1
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 1
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 1
- 240000008467 Oryza sativa Japonica Group Species 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 1
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 1
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 1
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 1
- 238000001190 Q-PCR Methods 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 1
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 1
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 1
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 1
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 1
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 1
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 1
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
- A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Agronomy & Crop Science (AREA)
- Microbiology (AREA)
- Dentistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses dsRNA for inhibiting pathogenicity of rice stripe virus and application thereof. The dsRNA disclosed by the invention targets the gene of the RSV3 pc3 protein, so that the replication and expression level of the rice stripe virus in a plant body are inhibited, and the occurrence of rice stripe disease is effectively reduced. The dsRNA disclosed by the invention is inhibited before virus infection, so that the pathogenicity of rice stripe viruses is greatly reduced; the biological antiviral agent prepared by using the dsRNA disclosed by the invention has the advantages of obvious plant disease resistance improving effect, safety, environmental friendliness, simple preparation process and stronger applicability.
Description
Technical Field
The invention belongs to the field of genetic engineering, and particularly relates to dsRNA for inhibiting rice stripe virus (Rice stripe virus, RSV) and a preparation method and application thereof.
Background
The rice stripe disease is a rice virus disease caused by the persistent transmission of RSV from the medium Laodelphax striatellus through eggs. Typical symptoms of rice plants infected by rice stripe viruses are formation of chlorosis stripe spots or plaques, and the typical symptoms are roughly classified into leaf rolling types and leaf spreading types, wherein the leaf rolling types show core leaf chlorosis, twist and arc ring sagging, severe core leaf death, leaf spreading type disease leaves do not twist, and yellow-green alternate stripes appear on leaf surfaces. Most of the plants with diseases cannot normally heading, so that the yield is seriously reduced. In 2000, rice stripe disease is widely popular in japonica rice planting areas at the downstream of Yangtze river in China, generally the yield is reduced by 20% -30%, the incidence rate of serious field blocks reaches 80% -90%, the yield loss is 7-8, and some grains are not harvested, so that serious threat is formed to agricultural production. In addition to damaging rice, RSV infects more than 80 grasses such as wheat, barley, oats, corn, and the like.
RNA interference (RNAi) is a process by which dsRNA (double-stranded RNA) recognizes mRNA having a homologous complementary sequence and inhibits its expression and even degrades its molecule, also known as gene silencing, which plays a very important role in eukaryotic protection against biotic stress. There are a large number of small cross-border RNAs in nature that are transmitted bi-directionally between plant-pathogens. dsRNA derived from pathogenic bacteria pathogenic genes is sprayed on the surface of a plant, so that an RNA silencing system in the plant can be induced, the expression of virus genes is inhibited, the pathogenicity of the virus genes is reduced, and the plant is effectively protected from being damaged by pathogenic bacteria. Therefore, the dsRNA based on the RSV genome is explored for preventing and treating viral diseases, the problems of lack of prevention and treatment medicaments for viral diseases in production, pollution caused by insect prevention and pesticide application, scarcity of resistant variety resources and the like are solved, and the method becomes a new means for researching green and environment protection.
Disclosure of Invention
The invention aims to: the first object of the present invention is to provide a dsRNA for inhibiting rice stripe virus by targeting a gene encoding rice stripe virus RSV3 pC3 protein.
The invention also solves the technical problem of providing the application of the dsRNA in inhibiting rice stripe virus.
The technical scheme is as follows: the RNA sequence of the dsRNA for inhibiting the pathogenicity of the RSV is shown as SEQ ID NO. 3.
The preparation method of the dsRNA comprises the following steps: PCR amplification is carried out by taking cDNA of RSV as a template and using a primer pair with a nucleotide sequence shown as SEQ ID NO. 1-2 to obtain a dsRNA fragment with a nucleotide sequence shown as SEQ ID NO.4, and the dsRNA fragment is connected to an expression vector to construct a recombinant vector; introducing a recombinant expression vector containing the dsRNA fragment into escherichia coli HT115 for culture; dsRNA production was induced by IPTG, and the bacterial liquid was collected by culture.
Wherein the expression vector is a commercially available pet28 vector.
Further, upon induction with IPTG, the initial concentration of E.coli HT115 was OD 600 =0.4-0.8; IPTG concentration is 0.5-1.0mmol/mL; the culture time is 4-5h.
The dsRNA is applied to preparation of medicines for preventing and treating rice stripe disease.
Further, the rice stripe disease is caused by RSV.
Further, the concentration of the dsRNA is 1.20-2.0 mug/. Mu.L.
The agent of the invention can be sprayed on the leaves or stems of rice.
The beneficial effects are that: compared with the prior art, the invention has the following remarkable advantages:
1. the dsRNA targets the gene for encoding the RSV3 pc3 protein of the rice stripe virus, and can play a role in preventing and treating rice stripe disease in early virus infection;
2. the bacterial induction dsRNA has low cost, high yield, simple process, strong specificity, obvious antiviral effect, safety and environmental protection, and ensures that the RNAi technology is better applied to the prevention and treatment of rice stripe disease.
Drawings
FIG. 1 selects the conserved domains (both ends) of segments;
FIG. 2 clustered distribution of small RNAs of non-conserved domains of selected segments;
FIG. 3 is a bacterial induction dsRNA electrophoresis pattern;
FIG. 4 is a graph of symptoms and bars of leaf blight disease of rice stripe in inoculated RSV strain treated with dsRNA of the present invention and non-inoculated control Wuyunj No.3 (WYJ 3), wherein the significant differences (p-value < 0.05) are shown;
FIG. 5 is a bar graph of the incidence of rice stripe disease analysis for each treatment group after treatment with dsRNA at different concentrations and virus inoculation according to the present invention;
FIG. 6 is a bar graph of the analysis of different disease grade phenotypes and different disease grade numbers for each treatment and control after treatment with dsRNA at different concentrations and virus inoculation according to the present invention;
FIG. 7 shows a western blot expression pattern of rice stripe virus proteins treated with dsRNA according to the invention, with Actin as a reference;
FIG. 8 is a bar graph showing the analysis of rice stripe virus content relative to expression in treated and control rice leaves after dsRNA treatment and virus inoculation according to the present invention.
Detailed Description
The technical solution of the present invention will be further described by way of example with reference to the accompanying drawings.
The materials and instruments used in the following examples are all commercially available, the rice material used is Wuyujing No.3, and the virus-carrying Laodelphax striatellus population carrying RSV is stored and screened by the plant protection institute of research institute of Agents for viral disease resistance, the institute of agricultural sciences, jiangsu province, where the applicant of the present invention is located.
The cDNA coding sequence of the RSV3 of the invention is derived from the National Center for Biotechnology Information databasehttps:// www.ncbi.nlm.nih.gov/gene) under the number NC003776.1Is a gene of (a). Firstly, the sequence is respectively compared with rice genome sequences (http:// rice. Plant biology. Msu/; http:// www.gramene, org /) in two rice genome databases through conservative comparison, so that the enrichment sections of the conservative regions at the two ends are eliminated, and the silent rice genes are eliminatedIs possible (fig. 1). And then, according to analysis, virus small RNAs of inoculated samples are distributed on a genome, and small RNA distribution areas enriched in high abundance are selected, so that the silencing efficiency is improved (figure 2). Finally, 327 bp base sequence in RSV3 was successfully amplified as a transcription template for the dsRNA of interest in the present invention.
The RNA sequence of the dsRNA molecule derived from RSV3 is shown as SEQ ID No.3, and the cDNA coding sequence is shown as SEQ ID No. 4.
SEQ ID No.3:
SEQ ID No.4
The cDNA coding sequence of RSV3 is derived from the gene numbered NC_003776.1 in the database of National Center for Biotechnology Information (https:// www.ncbi.nlm.nih.gov/nucleic /). The base sequences 1207-1608 of the cDNA coding sequence of ORF2 were selected as template sequences for the dsRNA of the invention. Again, this sequence was aligned with the rice genome sequences (http:// rice. Plant biology. Msu. Edu/; http:// www.gramene.org /) in the two rice genome databases, respectively, and the likelihood of nonspecific silencing of the rice genes was examined. The comparison result shows that the dsRNA molecule of the invention can not reach the effective length of RNA silencing rice genome, and further eliminates the possibility that the fragment interferes with silencing rice genes.
The dsRNA molecules of the present invention (the cDNA sequence of which is shown in SEQ ID No. 4) were amplified from the cDNA of RSV3 ORF3 saved by the institute of plant protection, proc. Natl.Acad. Jiang Susheng.
The invention classifies the symptoms of leaf blight of rice into the following categories by referring to the industry standard NYT2055/2011 of Ministry of agriculture, namely the identification technical Specification of leaf blight of rice variety:
grade 0, asymptomatic;
grade I, with slight yellow-green mottle and mottle symptoms, the disease leaves are not curled, and the plant grows normally;
stage II, the chlorosis and the development on the disease leaves are connected into irregular yellow-white or yellow-green strip spots, the disease leaves are not curled or slightly curled, and the growth is basically normal;
and III, seriously fading the diseased leaves, twisting the curled diseased leaves, and causing the diseased leaves to have yellowing wither symptoms, and causing the plants to be withered in a pseudo-withered heart shape or dead whole plants.
Example 1: preparation of bacterial induced expression dsRNA preparation
(1) Construction of vectors and recombinants:
1.1 extraction of rice stripe virus RNA: the leaf of the diseased rice plant was collected and the intermediate RNA was extracted by TRIzol (TaKaRa) method. The specific operation is as follows:
1.1.1, uniformly grinding a proper amount of rice plant leaves by using liquid nitrogen, and rapidly transferring the ground powdery or liquid substances into a 1.5mL RNase-free centrifuge tube.
1.1.2, 1mL of Trizol is rapidly sucked into a centrifuge tube, 200 mu L of chloroform is added into the centrifuge tube, and the liquid in the tube is stirred and mixed uniformly and then kept stand for 5min at 4 ℃.
1.1.3, 4℃and 12000rpm for 15min.
1.1.4, the supernatant after centrifugation was sucked into a new 1.5mL RNase-free centrifuge tube, 600. Mu.L isopropyl alcohol was added into the centrifuge tube, and the centrifuge tube was allowed to stand at-80℃for 2 hours.
1.1.5, 4 ℃,12000rpm for 15min, discarding the supernatant.
1.1.6, 1mL of 75% ethanol solution was pipetted into a centrifuge tube, the pellet resuspended by pipetting, and centrifuged at 12000rpm for 3-5min at 4℃and the supernatant discarded.
1.1.7, repeating the step 1.6 once, then carrying out air separation once, and sucking residual liquid by using a liquid transfer device.
1.1.8, drying the precipitate until the precipitate is transparent, adding 30 mu L of RNase-free Water into a centrifuge tube, and sucking and beating the precipitate by a pipette to fully dissolve the precipitate, thus obtaining the total RNA of the leaf blades of the rice plants.
1.2 transcription of Rice stripe Virus template, RNA concentration was adjusted to 500 ng/. Mu.L, primeScript was selected TM RT reagent Kit gDNA Eraser (TaKaRa) kit reverse transcribes the total RNA extracted into cDNA. Specific primers containing two cleavage sites of Sac I and Xho I are designed according to sequence information, and PCR amplification is carried out by taking cDNA of RSV3 as a template. The primer sequences were as follows:
F:5’-CGAGCTCGGCTCTACTAGAGAGTGAACAAT-3’(SEQ ID NO.1);
R:5’-CCGCTCGAGATGGGAAAGTGAAGACCACAATC-3’(SEQ ID NO.2)。
the underlined part is the site of the introduced cleavage.
1.3, detecting the amplified product by 1.0% agarose gel electrophoresis, showing that a single band exists at about 400bp, and the size of the single band is consistent with that of the expected sequence, and performing gel recovery and purification.
1.4 double restriction fragments were purified together with a laboratory-stored pet28 vector (purchased from the commercial company Tianzenzetiand z, mianyang, china) and the restriction fragments and vector were ligated using T4 DNA Ligase (TaKaRa) to obtain recombinant plasmids.
1.5 preparation of GFP dsRNA fragments for control treatment reference is made to Annete Niehl et al, new Phytologist. ( Double-stranded RNAs induce a pattern-triggered immune signaling pathway in plants.New Phytologist Volume 211, issue3, https: (v)/doi. Org/10.1111/nph.13944 )
1.6, transforming the recombinant plasmid into Escherichia coli competent HT115 preserved in a laboratory to obtain a desired recombinant, and preserving glycerol bacteria.
(2) Bacteria induce expression of dsRNA. The specific operation is as follows:
2.1 Induction of expression of dsRNA
The stored glycerinum containing the target gene is prepared according to the following steps: the volume ratio of the culture solution is 1:100 (12.5. Mu.g/mL Tet) + ,50μg/mL Amp + ) In LB sterile culture medium. Placing in a constant temperature shaking table at 37 ℃ and 220rpm overnight for preliminary culture.
In an ultra-clean workbench, the primary culture liquid is sucked up according to the volume ratio of 4:100 in a proportion of 400mL of liquid LB sterile culture medium (500 mL conical flask) containing ampicillin and tetracycline resistances (concentration as above), and placing in a constant temperature shaker at 37℃and expanding culture at 220rpm for 2h to OD 600 =0.4-0.8。
Sterile IPTG was added to the super clean bench at a final concentration of 1.0mmol/L, and the culture was continued for 5 hours under the above conditions.
2.2 extraction of total RNA from E.coli HT115 using TRIzol (TaKaRa) method, for specific procedures reference is made to example 1, step 1.1.
2.3 purification and characterization of induced dsRNA
2.3.1 Total RNA from E.coli was treated with DNase I (final concentration 200U/ml) at 37℃for 30min and then RNase A (final concentration 100. Mu.g/. Mu.l) at 37℃for 30min.
2.3.2, measuring the concentration of dsRNA by using a spectrophotometer, wherein the yield of total RNA extracted by the method can reach 5mg per 200ml bacterial liquid, and carrying out agarose gel electrophoresis on the dsRNA to verify the size of a band so as to confirm whether the dsRNA is successfully synthesized. The results are shown in FIG. 3, confirming successful synthesis of correct dsRNA. According to the estimated result of the electrophoresis diagram, the dsRNA content in the expression system of the invention accounts for 40% -60% of the total RNA, namely, the yield of bacterial liquid per 200ml can reach 2-3mg, the original concentration can reach 2-4 mug/mu l, and the yield is improved by two times compared with the conventional level. The final concentration of dsRNA was adjusted to 1.5. Mu.g/. Mu.l with DEPC water and stored as test treatment fluid.
Example 2: in vivo inoculation of RSV in rice and detection of the pathogenicity and expression level of dsRNA in inhibiting RSV
(1) The extraction of rice stripe virus RNA is described in step 1.1 of example 1.
(2) Rice inoculation RSV
Healthy Wuyujing No.3 rice seedlings are cultivated in a growing cup (35 strains per cup), when the seedlings grow to a leaf stage of 1.5, the finally expressed dsRNA product is mixed with RNase-free water, the concentration is regulated to 1.5 mug/mu l, 800 mu l of the mixture is sprayed per cup, and the total amount of 1200 mu g is uniformly sprayed on leaf surfaces and stems. Substitution of dsRNA solution with RNaseF reee ddH 2 O and GFP dsRNA at a concentration of 1.5. Mu.g/. Mu.l as non-viralTreatment control of dsRNA. After 24 hours of treatment, the rice is inoculated with 3-4-year old Laodelphax striatellus population with high toxicity, the insect quantity of each cup of rice seedling to be inoculated is calculated according to 1.5 head insects of each effective plant, the Laodelphax striatellus with corresponding insect quantity is sucked by a simple insect sucking device, and 58 head insects are inoculated in each cup (taking 90 percent of the toxic rate as an example). The high virulent population of Laodelphax striatellus used in this example was a high affinity population of Laodelphax striatellus with virulent (RSV) obtained by multiple generation screening in the laboratory, and derived from Liu Haijian et al (2007) and Zhou Tong et al (Liu Qing Jian, cheng Zhaobang, wang Yue, wei Bangqing, ren Chunmei, zhou Yijun, fan Yongjian, 2007. Laodelphax striatellus transmitted Rice stripe virus Industy. Jiangsu agricultural journal, 23 (5): 492-494; zhou Tong, fan Yongjian, cheng Zhaobang, et al. Study of Rice stripe disease resistance identification methods [ J]Plant protection 2008.34 (6): 77-80). And (5) after 48 hours of inoculation, the Laodelphax striatellus is swept out, then the seedlings are transplanted into a test field, and the disease condition is observed. After 5d the phenotype was observed by sampling. 3 strains of materials are mixed for each treatment, and the incidence of living organisms is detected after 14 days.
(3) In vivo RNA extraction and quantitative expression
Total RNA of the above rice samples was extracted using TRIzol reagent (Invitrogen), and the expression level of RSV was analyzed by real-time quantitative PCR after reverse transcription in accordance with steps 1.1 and 1.2 of reference example 1.
As can be seen from FIG. 4, plants that were re-infected with RSV after treatment with the dsRNA of the present invention, were treated with H 2 The incidence of treated samples was significantly reduced compared to GFP dsRNA control. As can be seen from FIG. 6, the relative expression level of RSV in the dsRNA treated rice plants was significantly reduced compared to the control.
From this, the above examples and data demonstrate that the dsRNA of the present invention has significant effects in inhibiting the pathogenicity of rice stripe disease and regulating the expression of rice stripe virus in plants.
EXAMPLE 3 Effect of aqueous dsRNA concentration on control Effect
dsRNA prepared in example 1 was dissolved in an aqueous solution to prepare aqueous solutions with concentrations of 0.5, 1.0, 1.5, 2.0 and 2.5. Mu.g/. Mu.l, and 800. Mu.l of each cup was uniformly sprayed on rice leaves, and after 24 hours of treatment, RSV (1.5 heads/seedling of effective virus carrying insects) was inoculated. And (5) after 48 hours of inoculation, the Laodelphax striatellus is swept out, the seedlings are transplanted into a test field, and the disease condition is observed after 14-20 days.
Table 1: optimal control concentration test for dsRNA-RSV3 aqueous solution
dsRNA concentration (μg/μl) | Prevention and control effect |
0.5 | 64.45% |
1.0 | 100.0 |
1.5 | 94.6 |
2.0 | 84.2 |
2.5 | 47.4 |
As can be seen from Table 1 and FIG. 5, the optimal control concentration was 1.0. Mu.g/. Mu.l. When the dsRNA concentration is 0.5 mug/mu l compared with 1.0 mug/mu l, the control level is obviously different, and the resistance improving effect is not obvious. There was no significant difference in control levels when the concentration of aqueous dsRNA solutions was between 1.0-2.0 μg/μl. When the concentration of dsRNA is up to 2.5 mug/mul, the prevention and treatment effect is not obviously improved, and the cost is increased.
As can be seen from FIG. 6, the number of disease stages II-III in the rice plants is reduced with the increase of the dsRNA concentration, which indicates that the disease symptoms of the plants are reduced and the resistance level is increased.
Example 4 detection of dsRNA having inhibitory Effect on Rice stripe Virus
Cultivating healthy Wuyujing No.3 rice seedling in a growing cup (35 plants per cup), and selecting dsRNA and DEPC-H with final concentration of 1.0 μg/μl when the seedling grows to 1.5 leaf stage 2 The mixture of O is added into a spray can treated by RNase scavenger (product No. 3090-250 of the Biotechnology Co., ltd., beijing Tianze) according to the volume of 800 μl per cup, and is uniformly sprayed on the leaf surface of the Wuyujing No.3 rice plant in the 1.5 leaf period. After the treatment, the pre-inoculated rice seedlings with the Wuyujing No.3 are transferred into a constant temperature culture room at 26 ℃ for 24 hours, and then RSV artificial inoculation is carried out, and the inoculation step is shown in example 2.
Experiments prove that after dsRNA is sprayed on plants, inoculated rice is moved to an identification garden, the virus expression level in the plants is detected, and Westen blot and Q-PCR results of FIG. 7 and FIG. 8 show that after the treatment of RSV 3dsRNA, the plants are treated with H 2 In vivo virus content was reduced in the plants of WYJ3 (WYJ 3) with martial transport for 7 days, 14 days, and 21 days (7 dpi,14dpi, and 21 dpi) compared to GFP dsRNA treatment.
By combining the results, the dsRNA has good effect of preventing and treating rice stripe viruses and has wide market application prospect.
Claims (9)
1. A dsRNA for inhibiting pathogenicity of rice stripe virus is characterized in that the sequence of the dsRNA is shown as SEQ ID NO. 3.
2. The method of producing dsRNA of claim 1, comprising the steps of: PCR amplification is carried out by taking cDNA of RSV as a template and using a primer pair with a nucleotide sequence shown as SEQ ID NO. 1-2 to obtain a dsRNA fragment with a nucleotide sequence shown as SEQ ID NO.4, and the dsRNA fragment is connected to an expression vector to construct a recombinant vector; introducing a recombinant expression vector containing the dsRNA fragment into escherichia coli HT115 for culture; dsRNA production was induced by IPTG, and the bacterial liquid was collected by culture.
3. The method of claim 2, wherein the expression vector is pet28 vector.
4. The method of claim 2, wherein the initial concentration of e.coli HT115 is OD 600 = 0.4-0.8。
5. The method of claim 2, wherein the IPTG concentration is 0.5-1.0mmol/mL.
6. The method of claim 2, wherein the incubation time is 4-5h.
7. The use of the dsRNA as defined in claim 1 for preventing and treating rice stripe disease.
8. The use according to claim 7, wherein the dsRNA is at a concentration of 1.0-2.0 μg/μl.
9. The use according to claim 7, characterized in that it comprises spraying an aqueous dsRNA solution onto rice leaves or stems.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311164495.7A CN117264953A (en) | 2023-09-08 | 2023-09-08 | dsRNA for inhibiting rice stripe virus, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311164495.7A CN117264953A (en) | 2023-09-08 | 2023-09-08 | dsRNA for inhibiting rice stripe virus, and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117264953A true CN117264953A (en) | 2023-12-22 |
Family
ID=89200013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311164495.7A Pending CN117264953A (en) | 2023-09-08 | 2023-09-08 | dsRNA for inhibiting rice stripe virus, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117264953A (en) |
-
2023
- 2023-09-08 CN CN202311164495.7A patent/CN117264953A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107936104B (en) | Peony PsMYB12 transcription factor and coding gene and application thereof | |
CN112626040B (en) | ZmRBOHB gene and application of encoding protein thereof in resistance to maize ear rot | |
CN113122552B (en) | Cucumber glutaredoxin gene CsGRX4 and application thereof to susceptibility of botrytis cinerea | |
CN110819635B (en) | Application of HAN homologous gene of leguminous plant in regulating and controlling number of root nodules of leguminous plant | |
CN112481294A (en) | Application of persimmon WRKY transcription factor gene in improvement of persimmon anthracnose resistance | |
CN110862996B (en) | Application of isolated soybean gene in improving soybean cyst nematode resistance | |
CN111187779B (en) | Disease-resistant gene OsRLR1, transcription factor OsWRKY19 and application in breeding of rice resistant to bacterial blight | |
CN105524150A (en) | Functional analysis and application of verticillium dahliae pathogenicity-related gene VdGFP | |
CN117264953A (en) | dsRNA for inhibiting rice stripe virus, and preparation method and application thereof | |
CN115261386A (en) | Double-stranded RNA molecule of targeted silent phytophthora capsici oxysterol binding protein 1 and application | |
CN111549042B (en) | Application of nucleic acid molecule in plant transgenosis, molecular breeding, disease control and molecular marker | |
CN108517322B (en) | Pinellia palmata trypsin inhibitor gene, protein coded by same and insect-resistant application | |
CN111635906A (en) | Gossypium barbadense GbCYP72A2 gene, and coding protein and application thereof | |
CN111808832A (en) | Gene of cation transfer ATP enzyme of rhizoctonia solani, fragment Rscta thereof and application | |
CN113005122B (en) | Anti-corn virus small RNA | |
US20230063483A1 (en) | Nucleic acid molecules, polypeptides having epoxy group-removing catalytic activity and use thereof | |
CN114634947B (en) | Method for inducing cotton PR5 gene silencing by TRV virus and application thereof | |
CN117821499B (en) | Biological material for regulating expression of TaWRKY24 protein coding gene and application thereof | |
CN108517007B (en) | Application of VdPHB gene in verticillium dahliae resistance | |
CN115109797B (en) | Application of rice OsPR6 gene or protein coded by same in regulation and control of rice blast germ resistance | |
CN115960952B (en) | Expression vector for over-expressing corn ZmHB53 gene, construction method and application thereof in improving drought tolerance of plants | |
CN116555279B (en) | Gene segment for enhancing lodging resistance of capsicum, coded protein thereof, detection kit, rapid detection method and application | |
CN112239763B (en) | Application of OsMYB63 gene in improving disease resistance of rice | |
CN114854752A (en) | Double-stranded RNA molecule for targeted silencing of phytophthora capsici cellulose synthase 3 and application thereof | |
CN117886909A (en) | Transcription factor PpBZR1.1 affecting plant resistance to black spot disease, and coding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |